COCH — Envoy Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $49.63m
- $45.89m
- $0.24m
Annual cashflow statement for Envoy Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.68 | -15.9 | -29.9 | -20.8 | -23.8 |
| Depreciation | |||||
| Non-Cash Items | 1.75 | 7.2 | 13.1 | 3.31 | 3.41 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.082 | -0.16 | -0.958 | -0.637 | 1.84 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.94 | -8.8 | -17.7 | -17.9 | -18.2 |
| Capital Expenditures | -0.125 | -0.218 | -0.153 | -0.98 | -0.179 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.125 | -0.218 | -0.153 | -0.98 | -0.179 |
| Financing Cash Flow Items | 0.058 | 0.092 | 11.7 | -0.916 | -0.889 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.06 | 8.09 | 21.8 | 20.2 | 16.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.987 | -0.938 | 4.04 | 1.26 | -1.74 |